Literature DB >> 16384894

Reproducibility and accuracy of measurements of free and total prostate-specific antigen in serum vs plasma after long-term storage at -20 degrees C.

David Ulmert1, Charlotte Becker, Jan-Ake Nilsson, Timo Piironen, Thomas Björk, Jonas Hugosson, Göran Berglund, Hans Lilja.   

Abstract

BACKGROUND: Long-term frozen storage may alter the results of prostate-specific antigen (PSA) measurements, mainly because of degradation of free PSA (fPSA) in vitro. We compared the effects of long-term storage on fPSA, total PSA (tPSA), and complexed PSA (cPSA) in serum vs EDTA-plasma samples.
METHODS: We measured fPSA and tPSA concentrations in matched pairs of archival serum and EDTA-plasma samples (stored frozen at -20 degrees C for 20 years) from a large population-based cohort in Malmö, Sweden. We also compared concentrations in age-matched men with those in samples not subjected to long-term storage, obtained from participants in a population-based study of prostate cancer screening in Göteborg, Sweden. These contemporary samples were handled according to standardized preanalytical and analytical protocols aimed at minimizing in vitro degradation. tPSA and fPSA measurements were performed with a commercial assay (Prostatus Dual Assay; Perkin-Elmer Life Sciences).
RESULTS: Concentrations of tPSA and fPSA and calculated cPSA (tPSA - fPSA) in archival plasma were not significantly different from those in contemporary serum from age-matched men. In archival serum, however, random variability of fPSA was higher vs plasma than in contemporary samples, whereas systematic error of fPSA analyses was similarly small in archival and contemporary serum and plasma.
CONCLUSIONS: Concentrations of tPSA and calculated cPSA were highly stable in plasma and serum samples subjected to long-term storage at -20 degrees C. Greater random variability, rather than a systematic decrease, may explain differences in fPSA analyses observed in archival serum.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16384894     DOI: 10.1373/clinchem.2005.050641

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  32 in total

1.  A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.

Authors:  Katharina Braun; Daniel D Sjoberg; Andrew J Vickers; Hans Lilja; Anders S Bjartell
Journal:  Eur Urol       Date:  2015-05-13       Impact factor: 20.096

2.  Stability of total and free prostate specific antigen in serum submitted to intermittent cold storage conditions.

Authors:  Asmahan A El Ezzi; Mohammed A El-Saidi
Journal:  Indian J Clin Biochem       Date:  2009-07-09

3.  Screening for Prostate Cancer Starting at Age 50-54 Years. A Population-based Cohort Study.

Authors:  Sigrid Carlsson; Melissa Assel; David Ulmert; Axel Gerdtsson; Jonas Hugosson; Andrew Vickers; Hans Lilja
Journal:  Eur Urol       Date:  2016-04-13       Impact factor: 20.096

4.  Predicting prostate cancer many years before diagnosis: how and why?

Authors:  Andrew J Vickers; Hans Lilja
Journal:  World J Urol       Date:  2011-11-20       Impact factor: 4.226

5.  Prostate specific antigen concentration at age 60 and death or metastasis from prostate cancer: case-control study.

Authors:  Andrew J Vickers; Angel M Cronin; Thomas Björk; Jonas Manjer; Peter M Nilsson; Anders Dahlin; Anders Bjartell; Peter T Scardino; David Ulmert; Hans Lilja
Journal:  BMJ       Date:  2010-09-14

6.  Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?

Authors:  Sigrid V Carlsson; Mari T Peltola; Daniel Sjoberg; Fritz H Schröder; Jonas Hugosson; Kim Pettersson; Peter T Scardino; Andrew J Vickers; Hans Lilja; Monique J Roobol
Journal:  BJU Int       Date:  2013-02-28       Impact factor: 5.588

7.  Stability of [-2]Pro-PSA in whole blood and serum: analysis for optimal measurement conditions.

Authors:  Tsukasa Igawa; Kosuke Takehara; Toru Onita; Kazuto Ito; Hideki Sakai
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

8.  Effect of thrombin tube on PSA determination, a clue for false negative in screening for prostate cancer.

Authors:  Viroj Wiwanitkit
Journal:  J Thromb Thrombolysis       Date:  2008-02-23       Impact factor: 2.300

Review 9.  Screening for prostate cancer: an update.

Authors:  Shahrokh F Shariat; Peter T Scardino; Hans Lilja
Journal:  Can J Urol       Date:  2008-12       Impact factor: 1.344

10.  Baseline prostate-specific antigen measurements and subsequent prostate cancer risk in the Danish Diet, Cancer and Health cohort.

Authors:  Signe Benzon Larsen; Klaus Brasso; Peter Iversen; Jane Christensen; Michael Christiansen; Sigrid Carlsson; Hans Lilja; Søren Friis; Anne Tjønneland; Susanne Oksbjerg Dalton
Journal:  Eur J Cancer       Date:  2013-05-17       Impact factor: 9.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.